[139] Personalized medicine approaches are gaining traction, with research focusing on identifying biomarkers and genetic profiles to predict patient response to GLP-1 RAs, potentially improving treatment outcomes
In the same press release, Almirall Chief Scientific Officer Karl Ziegelbauer called the expanded approval a significant step forward for both patients and treating dermatologists, adding that the latter are looking for ways to treat the entire affected area to help prevent further lesion progression. June 7 Product: Gerons Rytelo Indication: Myelodysplastic syndromes Geron Corporation kicked off the weekend on a high note as the FDA approval of its telomerase inhibitor Rytelo for myelodysplastic syndromes (MDS)a group of blood cancerssent the companys stock soaring more than 30%
It has been reported that fungi do not contain orthologs of bacterial EgtA or EgtC (Jones et al., 2014), which indicates that there is no -glutamylcysteine synthase to produce -glutamylcysteine, or a glutamate amidotransferase to cleave the -glutamyl residue
limited post-marketing data
The PMC systematic review noted that tirzepatide was the most commonly studied GLP-1 in recent hair loss research, and some studies actually showed hair regrowth in certain cases
